Patient Experience
Speciality: Speciality
Sub specialities: Women and Girls with Bleeding Disorder, Heavy Menstrual Bleeding, Von Willebrand Disease, Haemophilia
Dr. Michelle Lavin is a Consultant Haematologist in the National Coagulation Centre, St. James’ Hospital and researcher in the Irish Centre for Vascular Biology, RCSI, Dublin. Her current research programme focuses on Low VWF, bleeding score analysis and improving diagnosis and care for Women and Girls with Bleeding Disorders (WGBD).
Dr. Lavin serves as the Chair of the World Federation of Haemophilia Von Willebrand Disease (VWD) and Rare Bleeding Disorder Committee and also as the Co-Chair of the European Association for Haemophilia and Allied Disorders (EAHAD) WGBD Working Group. She is an Associate Member of the International Federation of Gynecology and Obstetrics (FIGO) Menstrual Disorders and Health Related Impacts Committee. She has served as an invited expert to the development of the 2021 ASH/ISTH/NHF/WFH Management of VWD guidelines & the 2021 EAHAD Principles of Care for WGBD. She previously served as a Co-Chair on the International Society on Thrombosis and Haemostasis Von Willebrand Factor Scientific Subcommittee.
Her outreach work includes collaboration with the Irish Haemophilia Society, the European Haemophilia Consortium and World Federation of Haemophilia to improve awareness on bleeding disorders and the impact of heavy menstrual bleeding.
Via Healthlink
Via post:
Name of department
St James's Hospital
Dublin 8